HuGE Literature Finder
Records
1
-
4
Prognostic Significance of Altered ATRX/DAXX Gene in Pancreatic Neuroendocrine Tumors: A Meta-Analysis. Frontiers in endocrinology 2021 12 691557. Wang Fei, Xu Xiaowu, Ye Zeng, Qin Yi, Yu Xianjun, Ji Shunro |
ATRX loss is an independent predictor of poor survival in pancreatic neuroendocrine tumors. Human pathology 2018 Aug . Chou Angela, Itchins Malinda, de Reuver Philip R, BSc Jennifer Arena, BSc Adele Clarkson, BSc Amy Sheen, BSc Loretta Sioson, MChD Veronica Cheung, Perren Aurel, Nahm Christopher, Mittal Anubhav, Samra Jaswinder S, Pajic Marina, Gill Anthony |
Exome Sequencing of Uterine Leiomyosarcomas Identifies Frequent Mutations in TP53, ATRX, and MED12. PLoS genetics 2016 Feb 12 (2): e1005850. Mäkinen Netta, Aavikko Mervi, Heikkinen Tuomas, Taipale Minna, Taipale Jussi, Koivisto-Korander Riitta, Bützow Ralf, Vahteristo P |
TERT promoter mutations are a rare event in gastrointestinal stromal tumors. SpringerPlus 2015 4 836. Akaike Keisuke, Toda-Ishii Midori, Suehara Yoshiyuki, Mukaihara Kenta, Kubota Daisuke, Mitani Keiko, Takagi Tatsuya, Kaneko Kazuo, Yao Takashi, Saito Tsuyos |
- Page last reviewed:Oct 1, 2021
- Page last updated:May 18, 2022
- Content source: